IMPROVED OUTCOME OVER TIME AFTER SECOND ALLOGENEIC STEM CELL TRANSPLANTATION IN RELAPSED AML. AN ANALYSIS OF 1540 PATIENTS ON BEHALF OF THE ALWP OF EBMT

被引：0

作者：

Schmaelter, Ann-Kristin ^{[1
]}

Ngoya, Maud ^{[2
]}

Galimard, Jacques-Emmanuel ^{[2
]}

Bazarbachi, Ali ^{[3
]}

Finke, Juergen ^{[4
]}

Kroeger, Nicolaus ^{[5
]}

Stoelzel, Friedrich ^{[6
]}

Stelljes, Matthias ^{[7
]}

Valerius, Thomas ^{[8
]}

Tischer, Johanna ^{[9
]}

Schroeder, Thomas ^{[10
]}

Dreger, Peter ^{[11
]}

Blau, Igor-Wolfgang ^{[12
]}

Savani, Bipin ^{[13
]}

Giebel, Sebastian ^{[14
]}

Esteve, Jordi ^{[15
]}

Nagler, Arnon ^{[16
]}

Schmid, Christoph ^{[1
]}

Ciceri, Fabio ^{[17
]}

Mohty, Mohamad ^{[2
,18
]}

机构：

[1] Univ Hosp Augsburg, Augsburg, Germany

[2] EBMT Paris Study Off, Paris, France

[3] Amer Univ, Beirut Med Ctr, Beirut, Lebanon

[4] Univ Freiburg, Freiburg, Germany

[5] Univ Med Ctr Hamburg Eppendorf, Hamburg, Germany

[6] Univ Hosp Dresden, Dresden, Germany

[7] Univ Munster, Munster, Germany

[8] Univ Med Ctr Schleswig Holstein, Kiel, Germany

[9] Univ Hosp Munich, Munich, Germany

[10] Univ Hosp Essen, Essen, Germany

[11] Heidelberg Univ, Heidelberg, Germany

[12] Charite Univ Med Berlin, Berlin, Germany

[13] Vanderbilt Univ, Med Ctr, Nashville, TN USA

[14] Maria Sklodowska Curie Canc Ctr & Inst Oncol, Gliwice, Poland

[15] Hosp Clin Barcelona, Barcelona, Spain

[16] Tel Aviv Univ, Chaim Sheba Med Ctr, Tel Aviv, Israel

[17] Univ Vita Salute San Raffaele, IRCCS Osped San Raffaele, Milan, Italy

[18] St Antoine Hosp, Paris, France

来源：

BONE MARROW TRANSPLANTATION | 2023年 / 58卷 / SUPP1期

关键词：

D O I：

暂无

中图分类号：

Q6 [生物物理学];

学科分类号：

071011 ;

摘要：

P275

引用

页码：341 / 342

页数：2

共 50 条

[21] Trends in patient outcome over the past two decades following allogeneic stem cell transplantation for acute myeloid leukaemia: an ALWP/EBMT analysis
Canaani, J.
Beohou, E.
Labopin, M.
Ghavamzadeh, A.
Beelen, D.
Hamladji, R. -M.
Niederwieser, D.
Volin, L.
Markiewicz, M.
Arnold, R.
Mufti, G.
Ehninger, G.
Socie, G.
Kroeger, N.
Mohty, M.
Nagler, A.
JOURNAL OF INTERNAL MEDICINE, 2019, 285 (04) : 407 - 418
[22] Outcome of Patients with Second Cancer after Hematopoietic Stem Cell Transplantation: On Behalf of the Complications and Quality of Life Working Party of the EBMT
Tichelli, Andre
Beohou, Eric
Labopin, Myriam
Socie, Gerard
Rovo, Alicia
Badoglio, Manuela
van Biezen, Anja
Basak, Grzegorz
Duarte, Rafael F.
Salooja, Nina
BLOOD, 2016, 128 (22)
[23] Second allogeneic hematopoietic stem cell transplantation in patients with acute leukemia relapsed after allogeneic hematopoietic stem cell transplantation
Choi, Yunsuk
Choi, Eun-Ji
Lee, Jung-Hee
Lee, Kyoo-Hyung
Jo, Jae-Cheol
Park, Han-Seung
Lee, Yoo Jin
Seol, Miee
Lee, Young-Shin
Kang, Young-Ah
Jeon, Mijin
Lee, Je-Hwan
CLINICAL TRANSPLANTATION, 2021, 35 (03)
[24] Treatment of relapsed AML and MDS after allogeneic stem cell transplantation with donor lymphocyte transfusion - A retrospective analysis of EBMT results.
Schmid, C
Alessandrino, E
Bunjes, D
Ferrant, A
Frassoni, F
Gluckman, E
Holler, E
Jacobsen, N
Ljungman, P
Schattenberg, A
Verdonck, L
Kolb, HJ
BLOOD, 2000, 96 (11) : 477A - 477A
[25] Prognostic Factors in Patients Receiving An Allogeneic Stem Cell Transplantation for Relapsed AML. Results of the Prospective AML 295 and 01/99 Studies
Krauter, Juergen
Heil, Gerhard
Hoelzer, Dieter
Martin, Hans
Ottmann, Oliver G.
Finke, Juergen
Luebbert, Michael
Heit, Wolfgang
Fiedler, Walter
Kanz, Lothar
Schlimok, Guenter
Kirchner, Hartmut
Raghavachar, Aruna
Brugger, Wolfram
Doehner, Hartmut
Ganser, Arnold
BLOOD, 2008, 112 (11) : 134 - 134
[26] Outcomes after autologous stem cell transplantation in AML patients using intravenous busulfan-based conditioning regimen. A survey on behalf of the ALWP-EBMT
Nagler, A.
Labopin, M.
Gorin, N.
Ferrara, F.
Torrez Gomez, A.
Lapusan, S.
Falda, M.
Gratwohl, A.
Rambaldi, A.
Botelho Sousa, A.
Bordessoule, D.
Shimoni, A.
Bunjes, D.
Colombat, P.
Cagirgan, S.
Jacobs, P.
Arcese, W.
Naparstek, E.
Martin-Reina, M. V.
Bouveur, B.
Berger, R.
Rocha, V.
Mohty, M.
BONE MARROW TRANSPLANTATION, 2012, 47 : S74 - S75
[27] The Impact of Cytogenetic Risk on Outcome of Non-T Cell Depleted Haploidentical Stem Cell Transplantation in Relapsed/Refractory AML: A Study From The ALWP/EBMT
Nagler, Arnon
Labopin, Myriam
Ciceri, Fabio
Tischer, Johanna
Blaise, Didier
Fanin, Renato
Bruno, Benedetto
Forcade, Edouard
Vydra, Jan
Chevallier, Patrice
Bulabois, Claude Eric
Jindra, Pavel
Stoelzel, Friedrich
Canaani, Jonathan
Sanz, Jaime
Savani, Bipin
Spyridonidis, Alexandros
Giebel, Sebastian
Brissot, Eolia
Bazarbachi, Ali
Esteve, Jordi
Mohty, Mohamad
BONE MARROW TRANSPLANTATION, 2021, 56 (SUPPL 1) : 25 - 26
[28] Transplantation Outcome By Disease Risk and Donor Type over Time: An Analysis of 100,000 Allogeneic Stem Cell Transplantation on Behalf of the Acute Leukemia Working Party of the EBMT
Shouval, Roni
Fein, Joshua
Labopin, Myriam
Kroger, Nicolaus
Duarte, Rafael F.
Bader, Peter
Chiara, Bonini
Kuball, Jurgen
Basak, Grzegorz
Dufour, Carlo
Lankester, Arjan
Montoto, Silvia
Snowden, John A.
Styczynski, Jan
Mohty, Mohamad
Nagler, Arnon
BLOOD, 2017, 130
[29] Feasibility and Outcomes of a Third Allogeneic Haematopoetic Stem Cell Transplantation: A Retrospective Analysis from the ALWP of EBMT
Rank, Andreas
Peczynski, Christophe
Labopin, Myriam
Stelljes, Matthias
Simand, Celestine
Helbig, Grzegorz
Finke, Juergen
Santarone, Stella
Tischer, Johanna
Lange, Andrzej
Mistrik, Martin
Houhou, Mohamed
Nagler, Arnon
Schmid, Christoph
Mothy, Mohamad
BONE MARROW TRANSPLANTATION, 2020, 55 (SUPPL 1) : 393 - 393
[30] Outcome of second cancer after hematopoietic stem cell transplantation: On behalf of the complications and quality of life working party of the EBMT
Tichelli, A.
Beohou, E.
Labopin, M.
Socie, G.
Rovo, A.
Badoglio, M.
van Biezen, A.
Basak, G.
Bader, P.
Duarte, R.
Salooja, Nina
BONE MARROW TRANSPLANTATION, 2017, 52 : S63 - S64

← 1 2 3 4 5 →